BioSymetrics

BioSymetrics is a biomedical AI company that supports healthcare and R&D innovation with leading data science expertise. By using AI to build a more comprehensive view of human health and drug research, it accelerates early drug discovery. BioSymetrics Inc. is transforming the scientific fields of massive data analysis and machine learning for complex biomedical data types through its groundbreaking preprocessing and analysis platform, Augusta™.Industry Field: By performing predictive analysis on various R&D and medical data used in drug research, BioSymetrics serves biopharmaceutical applications as well as CROs, hospitals, and health systems.Machine Learning Technology: Contingent-AI™ is a patent-pending automatic iterative framework that addresses bias detection and correction during the machine learning preprocessing phase and can determine additional analytical feature sets based on decisions made during bias reduction.The combination of machine learning technology with experimental practices allows BioSymetrics to uniquely integrate computational and in vivo work, providing a faster and more precise set of predictive outcomes for drug discovery research.